{"schema_version":"secwatch.filing_event.v1","accession":"0001161697-25-000371","form_type":"8-K","ticker":"KRMD","cik":"0000704440","company_name":"KORU Medical Systems, Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.941608+00:00","generated_at":"2026-05-16T21:55:11.696063+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"KORU Medical Q3 revenue $10.4M (+27% YoY), raises full-year guidance","bullets":["Q3 net revenues $10.4M, up 27% YoY; core business (domestic + international) $9.8M, up 30%.","Net loss narrowed 51% to $0.8M; positive adjusted EBITDA of $0.09M vs. $(0.4M) prior year.","International core revenue surged 229.6% to $3.7M; domestic core declined 5.0%.","Raising FY2025 revenue guidance to $40.5-41.0M (from $39.5-40.5M); gross margin guidance reiterated at 61-63%.","Ending cash balance $8.5M; generated $0.4M cash in Q3; reiterating positive full-year cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0001161697-25-000371","json":"https://secwatch.observer/filing/0001161697-25-000371.json","markdown":"https://secwatch.observer/filing/0001161697-25-000371.md","text":"https://secwatch.observer/filing/0001161697-25-000371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/0001161697-25-000371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/704440/000116169725000371/form_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:55:11.696063+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}